Special Report

Cannabis and the Legal Industry: New Rules, New Risks, New Opportunities

The state-by-state legalization of marijuana for medical and recreational use has created a complicated legal landscape—and with it new demands for lawyers to responsibly advise cannabis clients and companies in adjacent industries. This special report features Law.com's in-depth coverage of emerging legal issues, key regulatory developments, and the lawyers who are helping to shape a new industry.


Thank you for sharing!

Your article was successfully shared with the contacts you provided.
marijuana money shutterstock

As New Jersey remains mired in debate on the legalization of recreational marijuana, New Jersey banks and regulators should begin to consider how best to tackle the thorny issue of banking the marijuana industry. Although this issue is not entirely new to New Jersey (since medicinal marijuana has been legal in the state since 2012), the inevitable onslaught of marijuana-related businesses (MRBs) if and when recreational use is legalized may cause this issue to be one of the most difficult to reconcile in the years following legalization.

The issue is both simple and complex. Marijuana remains a Schedule I substance under the Controlled Substances Act (CSA), sharing that designation with such drugs as heroin, LSD and MDMA. See 21 U.S.C. 812(b)(1). The designation signifies that the substance has a high potential for abuse and no accepted medical use. However, despite being illegal for all purposes under federal law, as of May 31, 2019, medicinal use of marijuana is legal in 33 states and recreational use is legal in 10 states (with Illinois poised to become the 11th state). An estimated 95% of the U.S. population lives in a state where cannabis (including CBD) is legal in some form.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.